122 related articles for article (PubMed ID: 35932932)
1. Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent.
Cristina Cardia M; Francesca Palmas M; Casula L; Pisanu A; Marceddu S; Valenti D; Sinico C; Pini E; Scerba MT; Tweedie D; Greig NH; Rosa Carta A; Lai F
Int J Pharm; 2022 Sep; 625():122079. PubMed ID: 35932932
[TBL] [Abstract][Full Text] [Related]
2. Pomalidomide Reduces Ischemic Brain Injury in Rodents.
Tsai YR; Tweedie D; Navas-Enamorado I; Scerba MT; Chang CF; Lai JH; Wu JC; Chen YH; Kang SJ; Hoffer BJ; de Cabo R; Greig NH; Chiang YH; Chen KY
Cell Transplant; 2019 Apr; 28(4):439-450. PubMed ID: 31094216
[TBL] [Abstract][Full Text] [Related]
3. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments.
Jung YJ; Tweedie D; Scerba MT; Greig NH
Front Cell Dev Biol; 2019; 7():313. PubMed ID: 31867326
[TBL] [Abstract][Full Text] [Related]
5. Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.
Wang JY; Huang YN; Chiu CC; Tweedie D; Luo W; Pick CG; Chou SY; Luo Y; Hoffer BJ; Greig NH; Wang JY
J Neuroinflammation; 2016 Jun; 13(1):168. PubMed ID: 27353053
[TBL] [Abstract][Full Text] [Related]
6. Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2.
Shrestha P; Davis DA; Jaeger HK; Stream A; Aisabor AI; Yarchoan R
PLoS Pathog; 2021 Jan; 17(1):e1009091. PubMed ID: 33411730
[TBL] [Abstract][Full Text] [Related]
7. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
[TBL] [Abstract][Full Text] [Related]
8. Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability.
Pireddu R; Caddeo C; Valenti D; Marongiu F; Scano A; Ennas G; Lai F; Fadda AM; Sinico C
Colloids Surf B Biointerfaces; 2016 Jul; 143():64-70. PubMed ID: 26998867
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by the Immunomodulatory Drug Pomalidomide in the
Casu MA; Mocci I; Isola R; Pisanu A; Boi L; Mulas G; Greig NH; Setzu MD; Carta AR
Front Aging Neurosci; 2020; 12():31. PubMed ID: 32116655
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.
Nooka AK; Joseph NS; Kaufman JL; Heffner LT; Gupta VA; Gleason C; Boise LH; Lonial S
Cancer; 2019 Sep; 125(17):2991-3000. PubMed ID: 31090928
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
Qiao H; Chen L; Rui T; Wang J; Chen T; Fu T; Li J; Di L
Int J Nanomedicine; 2017; 12():1033-1046. PubMed ID: 28223797
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole.
Sun Y; Chen D; Zhao Y; Zhou K; Zhang B; Wang H; Xie S
Drug Deliv Transl Res; 2022 May; 12(5):1219-1229. PubMed ID: 34148210
[TBL] [Abstract][Full Text] [Related]
13. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability.
Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q
AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466
[TBL] [Abstract][Full Text] [Related]
15. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation.
He Y; Xia DN; Li QX; Tao JS; Gan Y; Wang C
Acta Pharmacol Sin; 2015 Sep; 36(9):1151-60. PubMed ID: 26256404
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
[TBL] [Abstract][Full Text] [Related]
18. Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data.
Offidani M; Corvatta L; Caraffa P; Leoni P; Pautasso C; Larocca A; Palumbo A
Expert Rev Anticancer Ther; 2014 May; 14(5):499-510. PubMed ID: 24738833
[TBL] [Abstract][Full Text] [Related]
19. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
20. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
Wang Y; Wang S; Xu Y; Wang P; Li S; Liu L; Liu M; Jin X
Int J Nanomedicine; 2020; 15():7601-7613. PubMed ID: 33116490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
